Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MS”

1,241 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,241 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Not applicableStudy completedNCT00336557
What this trial is testing

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Post-approval studies (Phase 4)Study completedNCT03610022
What this trial is testing

Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1

Who this might be right for
Metastatic Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
University Hospital, Bordeaux 27
Large-scale testing (Phase 3)Ended earlyNCT01416181
What this trial is testing

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Biogen 889
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Large-scale testing (Phase 3)Ended earlyNCT01047319
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,047
Testing effectiveness (Phase 2)WithdrawnNCT01086371
What this trial is testing

Rhythmic Auditory Stimulation and Walking Performance in Multiple Sclerosis (MS) Patients

Who this might be right for
Gait Disturbance in Multiple Sclerosis Patients
The Cleveland Clinic
Not applicableUnknownNCT05590533
What this trial is testing

Turkish Version of F-2-MS

Who this might be right for
Cultural AdaptationReliabilityValidity+2 more
Pamukkale University 180
Not applicableStudy completedNCT04158063
What this trial is testing

Cognitive-motor Interference in Persons With MS

Who this might be right for
Multiple Sclerosis
Hasselt University 112
Not applicableUnknownNCT04002492
What this trial is testing

Effects of a Weight Based Training Program on MS Patients

Who this might be right for
Multiple Sclerosis
Holy Name Medical Center, Inc. 25
Not applicableStudy completedNCT03094364
What this trial is testing

Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisHemiparesis
University of Massachusetts, Lowell 31
Early research (Phase 1)WithdrawnNCT05029609
What this trial is testing

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisMultiple Sclerosis
Tiziana Life Sciences LTD
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Testing effectiveness (Phase 2)Study completedNCT00781872
What this trial is testing

Mesenchymal Stem Cells for the Treatment of MS

Who this might be right for
Multiple Sclerosis
Hadassah Medical Organization 24
Testing effectiveness (Phase 2)Study completedNCT00882999
What this trial is testing

Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Eli Lilly and Company 245
Not applicableStudy completedNCT00710645
What this trial is testing

Lido Workset Study

Who this might be right for
Multiple Sclerosis
University of California, Davis 31
Not applicableStudy completedNCT03373344
What this trial is testing

Remediation of Emotional Processing Deficits in MS

Who this might be right for
Multiple Sclerosis
Kessler Foundation 39
Testing effectiveness (Phase 2)Looking for participantsNCT06189833
What this trial is testing

Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 200
Load More Results